Novel Combinations of Rate-Controlling Polymers for the Release of Leuprolide Acetate in the Colon

REFERENCES

• Ashford M., Fell J., Attwood D., et al. An in vitro investigation into the suitability of pH dependent polymers for colonic targeting. Int. J. Pharmaceut. 1993; 91: 241–245
   Web of Science ®Google Scholar
• Augst A. D., Kong H. J., Mooney D. J. Alginate hydrogels as biomaterials. J. Pharmaceut. Pharmacol. 2006; 6(8)623–633
   Google Scholar
• Chourasia M. K., Jain S. K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharmaceut. Sci. 2003; 6(1)33–66
   PubMed Web of Science ®Google Scholar
• Cole E. T., Scott R. A., Connor A. L., et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. Int. J. Pharmaceut. 2002; 231: 83–95
   PubMed Web of Science ®Google Scholar
• Dew M. J., Ryder E. J., Evans N. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis. Br. J. Clin. Pharmacol. 2002; 16: 185–187
   Google Scholar
• Evans D. F., Pye G., et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035–1041
   PubMed Web of Science ®Google Scholar
• Fetih G., Fausia H., et al. Colon specific delivery and enhanced colonic absorption of Asu(1,7) eel calcitonin using chitosan capsules containing various additives in rats. J. Drug Target. 2006; 14(3)165–172
   PubMed Web of Science ®Google Scholar
• Gazzaniga A., Iamartino P., Maffione G., et al. Oral delayed release system for colon specific delivery. Int. J. Pharmaceut. 1994; 108: 77–83
   Web of Science ®Google Scholar
• Green J. T., Evans B. K., et al. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br. J. Clin. Pharmacol. 1999; 48: 485–493
   PubMed Web of Science ®Google Scholar
• Guo J., Ping Q., Jiang G., Dong J., Li S., Feng L., Li Z., Li C. Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer. Int. J. Pharmaceut. 2004; 278: 415–422
   PubMed Web of Science ®Google Scholar
• Ibekwe V. C., Fadda H. M., et al. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int. J. Pharmaceut. 2006; 308: 52–60
   PubMed Web of Science ®Google Scholar
• Liptay S., Weidenbach H., Alder G., Schmid R. M. Colon epithelium can be transiently transfected with liposomes, calcium phosphate precipitation and DEAE dextran in vivo. Digestion 1998; 59: 142–147
   PubMed Web of Science ®Google Scholar
• Liu L. S., Kende M., et al. Pectin/Zein beads for potential colon-specific drug delivery: synthesis and in vitro evaluation. Drug Delivery 2006; 13(4)1–7
   PubMedGoogle Scholar
• Lußen H. L., de Leeuw B. J., Langemeyer M. W. E., de Boer A. G., Verhoef J. C., Junginger H. E. Mucoadhesive polymers in peroral peptide drug delivery. IV. Carbomer and chitosan improve the intestinal absorption of the peptide drug burselin in vivo. Pharmaceut. Res. 1996; 13: 1668–1672
   PubMed Web of Science ®Google Scholar
• Ofori-Kwakye K., Fell J. T., Sharma H. L. Gamma scintigraphic evaluation of film coated tablets intended for colonic or biphasic release. Int. J. Pharmaceut. 2004; 270: 307–313
   PubMed Web of Science ®Google Scholar
• Okada H., Heya T., Ogawa Y., et al. One month release injectable microcapsules of a lutenizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J. Pharmacol. Exp. Therap. 1988; 244(2)744–750
   PubMed Web of Science ®Google Scholar
• Prego C., et al. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharmaceut. Res. 2006a; 23(3)549–556
   PubMed Web of Science ®Google Scholar
• Prego C., Torres D., et al. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: effect of chitosan pegylation degree. J. Control. Rel. 2006b; 111: 299–308
   PubMed Web of Science ®Google Scholar
• Rha C. K., Rodriguez-Sanchez D., Kienzle-Sterzer C. Novel applications of chitosan. Biotechnology of Marine Polysaccharides, R. R. Colwell, E. R. Pariser, A. J. Sinskey. McGraw Hill, New York 1985; 283–312
   Google Scholar
• Roberts G. A. F. Structures of chitin and chitosan. Chitin Chemistry, G. A. F. Roberts. MacMillan, London 1992; 1–53
   Google Scholar
• Rowe R. C., Sheskey P. J., Weller P. J. Handbook of Pharmaceutical Excipients, 4th ed. Pharmaceutical Press and American Pharmaceutical Association, Bath, UK 2003; 447–450
   Google Scholar
• Rowland R. N., Woodley J. F. The uptake of distearyphosphatidylcholine/ cholesterol liposomes by rat intestinal sac in vitro. Biochem. Biophys. Acta 1981; 673: 399–406
   Google Scholar
• Sanford P. A. Chitosan and alginate: new forms of commercial interest. Am. Chem. Soc. Div. Polymer Chem. 1990; 89: 151–165
   Google Scholar
• Shargel L. Encyclopedia of Pharmaceutical Technology, J. Swarbrick. Informa Healthcare, London, UK 2000; 208
   Google Scholar
• Steed K., Hooper G., Monti N., et al. The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (TIME CLOCK® system). J. Control. Rel. 1997; 49: 115–122
   Web of Science ®Google Scholar
• Takaya T., Ikeda C., Imagawa N. Development of a colon specific delivery capsule and the pharmacological activity of recombinant human granulocyte colony stimulating factor (rhG-CSF) in beagle dogs. J. Pharm. Pharmacol. 1995; 47: 474–478
   PubMed Web of Science ®Google Scholar
• Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki Yamamoto A., Muranishi S. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharmaceut. Sci. 1997; 86: 1016–1021
   PubMed Web of Science ®Google Scholar
• Vyas S. P., Venugopalan P., Sood A., Mysore N. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes. Pharmazie 1997; 52: 339–345
   PubMed Web of Science ®Google Scholar
• Wilding I. R., Davis S. S., O'Hagan D. T. Targeting of drugs and vaccines in the gut. Pharmacol. Therap. 1994; 62: 97–124
   PubMed Web of Science ®Google Scholar
• Wilson P. J., Basit A. W. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylase coated tablets. Int. J. Pharmaceut. 2005; 300: 89–94
   PubMed Web of Science ®Google Scholar
• Zheng Y., Qiu Y., et al. Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats. Int. J. Pharmaceut. 1999; 185: 83–92
   PubMed Web of Science ®Google Scholar